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seeded cells on passive diffusion for oxygen and nutri-
ent delivery remains a limiting factor in the in vitro con-
struction process before implantation. We have also
grown fetal rat cardiomyocytes in a similar mesh. These
cardiomyocytes proliferated and formed a spontaneous-
ly rhythmically contractile graft that survived and con-
tracted both in vitro and in vivo.3
A number of issues, however, remain to be resolved.
These include the determination of the optimal number,
cell type, and mixture of cell types to be seeded, as well
as the length of time required for in vitro generation of
these grafts before implantation, which affects clinical
utility. The optimal biodegradable substrate has yet to
be determined, both for support of graft cellular ele-
ments and for ease of handling during surgical implan-
tation. The long-term behavior of these grafts must also
be evaluated. Stock and colleagues1 noted bulging of
the unseeded biopolymer graft after 20 weeks, perhaps
representing the beginning of aneurysmal dilatation. We
have noted similar findings in cell-seeded gelatin grafts
implanted into the right ventricular outflow tract of rats.
Over the limited duration of these experiments, cell-
seeded patches did not appear to dilate in the same man-
ner as unseeded patches. Longer follow-up will be
required, however, to determine whether late aneurys-
mal dilation, particularly when the graft is subjected to
higher pressures and stresses in the left-sided circula-
tion, will become a liability of these materials.
These types of tissue-engineered grafts may in the
future become the ideal materials for the surgical repair
or palliation of congenital cardiac defects. Ultimately,
these grafts may offer the promise of a single operation
that will last the patient indefinitely, reducing the mor-
bidity and mortality and improving the quality of life of
these children.
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Commentary
The surgical repair of congenital cardiac defects,
including relief of stenotic lesions and reconstruction of
complex cardiac anomalies, often requires patch recon-
struction or placement of a synthetic conduit. Although
a number of graft materials are available for use in these
applications, the long-term results of reconstructive
procedures with these materials are limited by their lack
of growth potential, thrombogenicity, and lack of con-
tractility. The ideal graft material would have growth
potential, be nonthrombogenic, and be able to contract
synchronously with surrounding normal myocardium if
used to replace a portion of the right or left ventricle.
Graft materials composed of viable cellular element
within a biodegradable scaffold that can undergo
remodeling or absorption may best meet these criteria.
Patches and conduits with these properties, once
implanted, might not require repeated re-replacement as
the child grows, a limitation that currently results in sig-
nificant morbidity and mortality.
A number of research groups have been involved in
the development of new materials with potential car-
diovascular applications. Dr Mayer’s laboratory has
been one of the pioneers in the development of tissue-
engineered heart valves and pulmonary artery con-
duits. Their previous studies have demonstrated that
vascular cells can be seeded into, and grown in, dif-
ferent biodegradable materials. These tissue-engi-
neered materials may be used to construct valve
leaflets and vascular conduits. In this study, Stock and
colleagues1 report the in vivo behavior of patches
composed of a rapidly degraded biopolymer, poly-4-
hydroxybutyric acid (P-4HB), into which ovine vas-
cular cells were seeded. These autologous cell-seeded
patches were implanted into the pulmonary artery of
the original donor animal. Histologic examination of
these patches at up to 6 months demonstrated near-
complete resorption of the P-4HB substrate and for-
mation of organized tissue by the seeded cells.
Increasing cellular and extracellular matrix content of
the seeded patches suggested proliferation and syn-
thetic activity of the cells within the graft.
We have examined the 3-dimensional growth charac-
teristics of rat cardiomyocytes, smooth muscle cells,
and endothelial cells, as well as human heart cells,
when seeded into a biodegradable gelatin mesh. These
cells can proliferate within the gelatin substrate, form-
ing tissue.2 Thicker grafts may be constructed by layer-
ing several grafts together, but the dependence of the
